Neutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injury

Circulation: Cardiovascular Interventions

Volumn 8, Issue 9, 2015, Pages

  Quintavalle, Cristina ^a   Anselmi, Chiara Viviani ^b,c   De Micco, Francesca ^d   Roscigno, Giuseppina ^e   Visconti, Gabriella ^d   Golia, Bruno ^d   Focaccio, Amelia ^d   Ricciardelli, Bruno ^d   Perna, Enzo ^a   Papa, Laura ^b,c   Donnarumma, Elvira ^f   Condorelli, Gerolama ^a,e   Briguori, Carlo ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Milan Unit   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d Clinica Mediterranea   (Italy)

^e CNR   (Italy)

^f IRCCS SDN   (Italy)

Author keywords

Contrast media; Kidney; Kidney disease; NGAL; Prognostic factor

Indexed keywords

CONTRAST MEDIUM; CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CONTRAST INDUCED ACUTE KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; ACUTE KIDNEY INJURY; BLOOD; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; METABOLISM; URINE; VERY ELDERLY;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANGIOPLASTY; BIOMARKERS; CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, CHRONIC; TRIIODOBENZOIC ACIDS;

EID: 84957629037     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.002673     Document Type: Article

References (30)

1. McCullough PA., Contrast-induced acute kidney injury. J Am Coll Cardiol 2008 51 1419 1428. doi: 10.1016/j.jacc.2007.12.035.
2. Chambers CE, Dehmer GJ, Cox DA, Harrington RA, Babb JD, Popma JJ, Turco MA, Weiner BH, Tommaso CL, Society for Cardiovascular Angiography and Interventions Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheter Cardiovasc Interv 2009 73 847 858. doi: 10.1002/ccd.22100.
3. Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, Chawla LS, Cruz D, Ince C, Okusa MD, ADQI 10 workgroup Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 2014 85 513 521. doi: 10.1038/ki.2013.374.
4. Cowland JB, Borregaard N., Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997 45 17 23. doi: 10.1006/geno.1997.4896.
5. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003 14 2534 2543
6. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P., Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005 365 1231 1238. doi: 10.1016/S0140-6736(05)74811-X.
7. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL., Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007 11 R84. doi: 10.1186/cc6089.
8. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT., Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 2008 52 425 433. doi: 10.1053/j.ajkd.2008.05.018.
9. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, Elger A, Maarouf O, Sola-Del Valle DA, O'Rourke M, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, Barasch J., Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 2012 59 246 255. doi: 10.1016/j.jacc.2011.10.854.
10. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S., Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006 26 287 292. doi: 10.1159/000093961.
11. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH III, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P., NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007 22 2089 2095. doi: 10.1007/s00467-007-0601-4.
12. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, NGAL Meta-analysis Investigator Group Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009 54 1012 1024. doi: 10.1053/j.ajkd.2009.07.020.
13. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR., The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011 57 1752 1761. doi: 10.1016/j.jacc.2010.11.051.
14. Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A., Cystatin C and contrast-induced acute kidney injury. Circulation 2010 121 2117 2122. doi: 10.1161/CIRCULATIONAHA.109.919639.
15. Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G, REMEDIAL II Investigators Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 2011 124 1260 1269. doi: 10.1161/CIRCULATIONAHA.111.030759.
16. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA III, Rittase RA, Norton HJ, Kennedy TP., Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004 291 2328 2334. doi: 10.1001/jama.291.19.2328.
17. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 S1 S266
18. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, CKD Prognosis Consortium Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013 369 932 943. doi: 10.1056/NEJMoa1214234.
19. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G., A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004 44 1393 1399. doi: 10.1016/j.jacc.2004.06.068.
20. Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M, BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011 58 907 914. doi: 10.1016/j.jacc.2011.05.023.
21. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 11 R31. doi: 10.1186/cc5713.
22. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF., Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J 2008 50 419 430. doi: 10.1002/bimj.200710415.
23. Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, Colombo A, Condorelli G., Contrast agents and renal cell apoptosis. Eur Heart J 2008 29 2569 2576. doi: 10.1093/eurheartj/ehn197.
24. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, Viltard M, Yu W, Forster CS, Gong G, Liu Y, Kulkarni R, Mori K, Kalandadze A, Ratner AJ, Devarajan P, Landry DW, D'Agati V, Lin CS, Barasch J., The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011 17 216 222. doi: 10.1038/nm.2290.
25. McIlroy DR, Wagener G, Lee HT., Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010 5 211 219. doi: 10.2215/CJN.04240609.
26. Haase-Fielitz A, Bellomo R, Devarajan P, Bennett M, Story D, Matalanis G, Frei U, Dragun D, Haase M., The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009 24 3349 3354. doi: 10.1093/ndt/gfp234.
27. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P., Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008 3 665 673. doi: 10.2215/CJN.04010907.
28. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J., Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008 148 810 819
29. Murray PT, Devarajan P, Levey AS, Eckardt KU, Bonventre JV, Lombardi R, Herget-Rosenthal S, Levin A., A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol 2008 3 864 868. doi: 10.2215/CJN.04851107.
30. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch J., Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006 15 442 449. doi: 10.1097/01.mnh.0000232886.81142.58.